About DotLab
DotLab is a Healthcare company based in Branford (United States) founded in 2016 by Heather Bowerman. Molecular diagnostic testing for endometriosis is provided via saliva-based biomarkers. DotLab has raised $10 million across 2 funding rounds from investors including Wilson Sonsini Goodrich & Rosati, HHS and CooperSurgical. The company has 11 employees. Its chief executive, as recorded, is Heather Bowerman. DotLab offers products and services including DotEndo. Its focus areas include Life Sciences, Women Health, In Vitro Diagnostic Tests and Endometriosis. Its legal entity is DOT LABORATORIES, INC. Its competitors include Miroculus, Mirvie and Epic Sciences; 3 of its 3 listed competitors have raised funding.
Company details
DotLab was founded in 2016 in Branford, United States, and operates in the medical diagnostics sector. A saliva-based liquid biopsy test, known as DotEndo, has been developed to detect specific miRNAs for early identification of endometriosis, avoiding invasive procedures like laparoscopy. The test is prescribed by physicians, who collect samples and forward them to the companys CLIA- and CAP-certified laboratory for analysis.
- Headquarters Branford, United States
- Employees 11
- Founders Heather Bowerman
- SectorsHealthcare
- Phone•••• ••••
- Website dotlab.com
- Social LinkedIn X Facebook Instagram
- Legal Name Dot Laboratories, Inc.
- Total Equity Funding$10M (USD)
in 2 rounds
- Latest Funding Round$10M (USD), Series A
Jul 2019
- InvestorsWilson Sonsini Goodrich & Rosati
& 4 more
- Employee Count11
Products & Services of DotLab
DotLab offers a comprehensive portfolio of products and services, including DotEndo.
Non-invasive blood test for detecting endometriosis biomarkers early.
Funding Insights of DotLab
DotLab has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 2
- Last Round Series A — $10M
- First Round $202,293
(May 2019)
- Investors Count 5
All 2 funding rounds of DotLab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2019 | $10M | Series A | – | CooperSurgical | |
| May 2019 | $202,293 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in DotLab
DotLab has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati, HHS and CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture and private equity investments are managed with global diversification. | tigerglobal.com | New York, United States | ||
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States | |
Provides investment management and capital services for clients. | 2002 | luxorcap.com | New York, United States | |
Provider of legal services to technology and life science companies | 1961 | wsgr.com | Palo Alto, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for DotLab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DotLab
7 people are tracked at DotLab (1 in leadership, 6 in board & advisors); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Heather Bowerman | Founder & CEO | Leadership |
Thomas Musci | Scientific Advisor | Board & advisors |
Harold J. Sauer | Scientific Advisor | Board & advisors |
Eric Surrey | Scientific Advisor | Board & advisors |
Robert Taylor | Scientific Advisor | Board & advisors |
Kristof Chwalisz | Scientific Advisor | Board & advisors |
Anula Jayasuriya | Scientific Advisor | Board & advisors |
Complete people profiles for DotLab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DotLab
3 dated milestones of DotLab across 3 years, from founding to its latest funding, stage changes and deals.
- Founded DotLab is founded.
- Funding First funding round of $202K.
- Funding Latest funding round, Series A, of $10.0M.
Competitors of DotLab
DotLab has 3 listed competitors in our database, 3 of them funded. They include Miroculus, Mirvie and Epic Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| miroculus.com | 2014 | San Francisco, United States | $48.42M | MicroRNA profiling platform is developed to detect genes in samples. | ||
| mirvie.com | 2019 | San Francisco, United States | $113.7M | 35 | Non-invasive blood tests for prenatal fetal health predictions are offered. | |
| epicsciences.com | 2008 | San Diego, United States | $204.5M | 98 | Non-invasive tests for detecting circulating tumor cells are provided. |
Detailed competitors of DotLab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DotLab
The website of DotLab (dotlab.com) receives about 3K visits a month.
- Monthly visits3K
▼ 12.4% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as DotLab (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dotlab
Complete news archive for DotLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DotLab
DotLab was founded in 2016 and raised its 1st funding round 3 years after it was founded.
DotLab is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
Heather Bowerman is the CEO of DotLab, as recorded in our data. They have also founded this company.
DotLab is a funded company, having raised a total of $10M across 2 funding rounds to date. The company's 1st funding round was a Grant of $202.29K, raised on May 2019.
DotLab has 11 employees.
DotLab was founded in 2016 in Branford, United States, and operates in the medical diagnostics sector. A saliva-based liquid biopsy test, known as DotEndo, has been developed to detect specific miRNAs for early identification of endometriosis, avoiding invasive procedures like laparoscopy. The test is prescribed by physicians, who collect samples and forward them to the companys CLIA- and CAP-certified laboratory for analysis.
DotLab's top competitors include Mirvie, Miroculus and Epic Sciences.
DotLab offers DotEndo.
DotLab has 5 investors. Key investors include Wilson Sonsini Goodrich & Rosati, HHS, CooperSurgical, Tiger Global, and Luxor Capital Group.
DotLab operates through Dot Laboratories, Inc..